Detalhe da pesquisa
1.
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Blood
; 140(11): 1229-1253, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653592
2.
MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications.
Haematologica
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546691
3.
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study.
Br J Haematol
; 202(1): 116-121, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096954
4.
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
Br J Haematol
; 202(3): 525-529, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217196
5.
Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results.
Blood
; 138(6): 427-438, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827139
6.
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
Blood
; 138(3): 213-220, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292324
7.
Hematological Oncology journal women in lymphoma special issue: Latest updates in nodal peripheral T-cell lymphoma.
Hematol Oncol
; 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37309261
8.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
J Natl Compr Canc Netw
; 21(11): 1118-1131, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935098
9.
Current Treatments in Mantle Cell Lymphoma.
Oncology (Williston Park)
; 37(8): 326-333, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37616519
10.
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.
Haematologica
; 107(3): 690-701, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792219
11.
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.
Ann Hematol
; 101(2): 335-340, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668982
12.
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia.
Int J Mol Sci
; 23(12)2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35743155
13.
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
Br J Haematol
; 195(5): 757-763, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34581433
14.
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Br J Haematol
; 194(4): 690-700, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296427
15.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.
J Natl Compr Canc Netw
; 19(11): 1218-1230, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781267
16.
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma.
Blood
; 131(11): 1183-1194, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29229594
17.
Delay in Cancer Screening and Diagnosis During the COVID-19 Pandemic: What Is the Cost?
Oncology (Williston Park)
; 34(9): 343, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965661
18.
COVID-19 Pandemic and Its Effects on Cancer Care, Both Good and Bad.
Oncology (Williston Park)
; 34(7): 244, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32674205
19.
Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma.
Br J Haematol
; 184(5): 744-752, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30520026
20.
To transplant or not to transplant: that is the question in PTCL.
Blood
; 140(9): 936-937, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048475